About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Terumo Shifts Focus from Oxymorphone Patch to Injectables
March 20, 2018
Click here to read more
Post navigation
Previous Post
Phosphagenics Placement Secures A$1.37 million
Next Post
Phosphagenics Newsletter – March 2018
Related Posts
Avecho investor update – webinar recording
June 25, 2020
June 25, 2020
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024
March 26, 2024
Notice of 2015 Annual General Meeting
April 22, 2015